Metraipolis › archive › dc_070391ade686

Development and preclinical evaluation of next-generation ΔsigH-based live candidate vaccines — Europe PMC PMID:40875531

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40875531
DOI
10.1172/jci.insight.195947
License (as archived)
solo-consultazione
Archived
2026-11-10T07:10:04.537Z
SHA-256 of the archived text
e13c24eef206ad38edbdf18afd47bbd8ae2047c92bebfa5321429094b61d184a
Stable URL of this page
https://metraipolis.com/documento/dc_070391ade686

How to cite

Development and preclinical evaluation of next-generation ΔsigH-based live candidate vaccines — Europe PMC PMID:40875531 — Europe PMC (en), https://europepmc.org/article/MED/40875531 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_070391ade686 (Metraipolis archive dc_070391ade686, sha256 e13c24eef206ad38edbdf18afd47bbd8ae2047c92bebfa5321429094b61d184a)
BibTeX
@misc{dc070391ade686,
  title = {Development and preclinical evaluation of next-generation ΔsigH-based live candidate vaccines — Europe PMC PMID:40875531},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40875531},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_070391ade686; sha256 e13c24eef206ad38edbdf18afd47bbd8ae2047c92bebfa5321429094b61d184a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40875531. Agents can read the archived copy with the MCP tool read_document.